Sleep Cycle AB (publ)

SSE:SLEEP.ST

32.8 (SEK) • At close February 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) SEK.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 63.4365.44261.57861.25460.90858.10856.25756.22554.71652.45950.08951.44745.444.10742.0141.87940.29739.20338.113
Cost of Revenue 28.11130.00932.64134.48527.50217.7514.19119.48612.07612.52912.52813.9988.34511.5647.4077.6924.6315.0625.193
Gross Profit 35.31935.43328.93726.76933.40640.35842.06636.73942.6439.9337.56137.44937.05532.54334.60334.18735.66634.14132.92
Gross Profit Ratio 0.5570.5410.470.4370.5480.6950.7480.6530.7790.7610.750.7280.8160.7380.8240.8160.8850.8710.864
Reseach & Development Expenses 00035.88800027.58400023.04100015.214000
General & Administrative Expenses 000-8.489000-17.74315.25513.57211.872-28.54519.6233.0519.399-11.7349.4037.9564.907
Selling & Marketing Expenses 00022.72700034.78600041.99700019.584000
SG&A 14.70614.44414.30614.23813.72713.03412.64317.04315.25513.57211.87213.45219.6233.0519.3997.859.4037.9564.907
Other Expenses 02.152000030.97615.21613.8213.56212.94816.3618.41110.90710.51911.3410.3559.9340.044
Operating Expenses 14.70614.44415.09614.23812.97927.62230.97632.25929.07527.13424.8229.81328.03143.95729.91819.1919.75817.8914.594
Operating Income 20.61220.98913.84312.53120.42712.73411.095.01113.56312.79312.7427.9769.024-11.4144.6855.71415.90716.25218.37
Operating Income Ratio 0.3250.3210.2250.2050.3350.2190.1970.0890.2480.2440.2540.1550.199-0.2590.1120.1360.3950.4150.482
Total Other Income Expenses Net 0.3610.4010.6880.810.6310.2770.5371.423-0.041-0.045-0.013-0.02-0.013-0.039-0.006-0.009-0.012-0.117-0.012
Income Before Tax 20.97321.3914.53113.16520.90213.00911.4515.13113.52212.74812.7298.019.011-11.4534.6795.70515.89516.13518.358
Income Before Tax Ratio 0.3310.3270.2360.2150.3430.2240.2040.0910.2470.2430.2540.1560.198-0.260.1110.1360.3940.4120.482
Income Tax Expense 4.3364.4293.0062.724.3242.6952.3791.082.7932.6462.6351.6311.877-2.3430.9721.2283.4113.483.932
Net Income 16.63716.9611.52410.17916.57710.3118.9334.05210.72910.10210.0946.3797.135-9.113.7064.47712.48512.65514.426
Net Income Ratio 0.2620.2590.1870.1660.2720.1770.1590.0720.1960.1930.2020.1240.157-0.2070.0880.1070.310.3230.379
EPS 0.820.840.570.520.820.510.450.20.550.520.520.340.37-0.50.190.230.640.650.74
EPS Diluted 0.820.840.570.520.820.510.450.20.540.510.510.330.36-0.480.190.230.640.650.74
EBITDA 23.1423.11616.82720.20322.72919.55212.8296.44514.94314.15513.9829.1099.705-11.27211.9625.74816.05116.41718.549
EBITDA Ratio 0.3650.3530.2730.3460.3840.2670.2330.1150.2730.270.2790.1770.214-0.2560.1150.140.3980.4190.487